Glaucoma and its treatment: a review

Area of Science:

• Ophthalmology
• Optometry

Background:

• Glaucoma is a prevalent eye condition, a primary cause of blindness in industrialized nations.
• Often asymptomatic in early stages, glaucoma can lead to irreversible vision loss if untreated.
• Classified into primary/secondary and open-angle/angle-closure types, secondary glaucoma stems from other diseases.

Purpose of the Study:

• To provide a comprehensive review of glaucoma, encompassing its various forms and treatment modalities.
• To highlight the importance of early diagnosis and intervention in preventing glaucomatous optic neuropathy.

Main Methods:

• Review of existing literature on glaucoma diagnosis and treatment.
• Analysis of clinical trial data on the efficacy of antiglaucoma medications.
• Categorization of treatment options based on therapeutic lines and invasiveness.

Main Results:

• Antiglaucoma medications, including beta-blockers and prostaglandin analogs, are effective in slowing disease progression.
• Second-line treatments include alpha-agonists and carbonic anhydrase inhibitors, with parasympathomimetic agents as third-line options.
• Laser trabeculoplasty and incisional surgery serve as alternatives for patients unresponsive to medical therapy.

Conclusions:

• Glaucoma management requires careful consideration of the risks, benefits, and costs associated with each treatment option.
• Effective treatment strategies aim to lower intraocular pressure, thereby minimizing the risk of progressive optic nerve damage.
• Integrated treatment approaches, combining medications, laser, and surgery, are essential for optimal patient outcomes.